An interventional study of High protein dose and Usual protein dose in Dysphagia, sponsored by National Institute of Respiratory Diseases, Mexico. Suspended at 1 site in Mexico. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by National Institute of Respiratory Diseases, Mexico · Not applicable, Interventional, and Treatment
The randomized clinical trial was discontinued due to an insufficient recruitment rate, which made it impossible to achieve the estimated sample size. Only four patients had been enrolled to date, resulting in insufficient statistical power
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this study is to evaluate the impact of the prescription of two doses of protein on the amount in kilograms of muscle mass and on the clinical evolution (time until safe swallowing, time until removal of the feeding stoma, number of hospital readmissions, feeding stoma infections, incidence of pneumonia, functionality, number of falls, fractures and mortality) at 6 months after hospital discharge in patients with enteral nutrition due to post-extubation dysphagia.
875 studies on the registry are indexed under Deglutition Disorders; 237 are open to participants now.
This study's planned enrollment of 128 is above the median of 60 across 581 interventional studies indexed under Deglutition Disorders.
Browse Deglutition Disorders studies →National Institute of Respiratory Diseases, Mexico is the lead sponsor of 17 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
100% of the energy requirements measured by indirect calorimetry (IC) or estimated, and a protein intake of 2.0 g/kg, will be prescribed
Other: High protein dose
100% of the energy requirements measured by IC or estimated, and a protein intake of 1.5 g/kg, will be prescribed.
Other: Usual protein dose
High dose of protein (2.0 g/kg) will prescribed for home enteral nutrition
Usual dose of protein (1.5 g/kg) will prescribed for home enteral nutrition
Muscle mass changes
Changes of muscle mass in kilograms measured by impedance bioelectric
Time frame: From randomization to 6 months
Swallow recovery
Time to safe swallowing diagnosed by fibroendoscopy evaluation of swallowing (FEES) and measured in months
Time frame: From randomization to 6 months
Duration of enteral nutrition indication
Time from discharge to feeding tube removal
Time frame: From randomization to 6 months
Feeding tube complications
Number of feeding tube infections, dysfunctions and oclusions during study period
Time frame: From randomization to 6 months
Muscle functionality changes
Changes in functionality measured by medical research council scale in a scale of 0-60 points
Time frame: From randomization to 6 months
Handgrip strenght changes
Changes in functionality assessed by handgrip strenght in kilogramos using a digital dynamometer
Time frame: From randomization to 6 months
Frailty complications
Number of falls and fractures during study period
Time frame: From randomization to 6 months
Hospital readmissions associated to dysphagia complications
Number of hospital readmissions assocciated to feeding tube infections, dysfunctions and oclusions during study period
Time frame: From randomization to 6 months
6-month mortality
All-cause mortality during study period
Time frame: From randomization to 6 months
Aspiration pneumonia incidence
Number of hospital readmissions due to aspiration pneumonia
Time frame: From randomization to 6 months
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2024 (actual). Primary completion is estimated for Dec 2026, 29 months after the start.
How these figures are worked out, and which studies are left out of them.
The randomized clinical trial was discontinued due to an insufficient recruitment rate, which made it impossible to achieve the estimated sample size. Only four patients had been enrolled to date, resulting in insufficient statistical power
The randomized clinical trial was discontinued due to an insufficient recruitment rate, which made it impossible to achieve the estimated sample size. Only four patients had been enrolled to date, resulting in insufficient statistical power
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is suspended, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Institute of Respiratory Diseases, Mexico